Sanofi and Aventis likely to merge.

Published: 2003-01-14 06:58:00
Updated: 2003-01-14 06:58:00
Leading French pharmaceutical companies,Aventis and Sanofi-Synthelabo are very likely to merge.

Chairman Jean-Francois Dehcq of Sanofi-Synthelabo indicated openly in an interview with Le Figaro on Jan. 9 about a merger possibility between two companies. He said ambiguously "We do not deny taki...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.